Get access to our best features

Cardiosense, Inc., Completes $15.1 Million Series A Financing to Advance Artificial Intelligence Platform for Heart Disease

Summary by Ground News
Cardiosense, Inc. has raised $15.1 million in Series A funding. The capital will be used to support team expansion, accelerate product development, and fund an expansive heart failure study. The Company's first clinical application focuses on improving the management of congestive heart failure (CHF)
Published 2 months ago · Chicago, United States

News Articles

More Filters
All
Left
Center
Right

Cardiosense, Inc., Completes $15.1 Million Series A Financing to Advance Artificial Intelligence Platform for Heart Disease

/PRNewswire/ -- Cardiosense, Inc., a Chicago-based digital health company leveraging artificial intelligence and multi-sensor devices to enable early detection...

2 months ago·United States
Read Full Article

Cardiosense, Inc., Completes $15.1 Million Series A Financing to Advance Artificial Intelligence Platform for Heart Disease

Cardiosense, Inc., a Chicago-based digital health company leveraging artificial intelligence and multi-sensor devices

2 months ago
Read Full Article

Clinical-grade wearables developer Cardiosense raises $15.1M in Series A financing

The Chicago-based digital health company is leveraging artificial intelligence and multisensor devices to develop tools that enable the early detection of cardiovascular disease.

2 months ago
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

100% of the sources are Center
prnewswire.com
C 100%
See less detail